June 16, 2026
Top News for Informatics
AMIA Comments on CMS Interoperability Standards and Prior Authorization for Drugs Proposed Rule
AMIA submitted comments on CMS’s proposed rule, Interoperability Standards and Prior Authorization for Drugs (CMS-0062-P), supporting efforts to modernize prior authorization through FHIR-based, interoperable, and machine-readable processes. AMIA urged CMS to prioritize workflows that reduce administrative burden, improve medication access, and support clinical decision-making at the point of care. Recommendations included stronger standards alignment, transparent and clinically meaningful denial explanations, robust API testing and reporting, enhanced patient access to authorization information, and guardrails for AI-enabled prior authorization tools. AMIA also emphasized the need
Member-Only Content
This content is only accessible by current Members. Please log in to view the full content.
Not a Member yet? Learn more about the exclusive benefits you'll receive and join today.